glp-1 drugs and parkinson's disease drug shows little benefit for people with | UCL News GLP-1 Agonists: A New Frontier
Description
JiCXueGFLijunCFengPLiDLiLet al
Because the mechanism of action of SGLT-2 inhibitors is dependent on kidney function, these agents are not recommended for patients with diminished renal function
However, this approach must be considered as an add-on rather than an alternative to the search for novel drugs
This dual action often produces more pronounced appetite suppression and potentially greater weight loss results compared to GLP-1-only medications
During a GLP-1 reset, elevated cortisol can accelerate weight regain and potentially interfere with receptor recovery processes
doi: 10.1097/FJC.0b013e3182949673
